68Ga-Exendin PET/CT检出双灶性胰岛素瘤并接受超声内镜引导射频消融治疗:迈向金标准管理?
本文报告一例48岁女性高胰岛素性低血糖患者,常规形态学与功能学检查均未发现肿瘤,68Ga-Exendin PET/CT最终检出2个亚厘米级胰腺胰岛素瘤。在PET引导下,双能光谱CT于术前确认病灶,随后行保守性超声内镜引导射频消融治疗,成功使血糖水平恢复正常。
要点
- 68Ga-Exendin PET/CT在常规检查阴性时检出2个亚厘米级胰腺胰岛素瘤。
- PET引导下双能光谱CT于术前确认病灶。
- 超声内镜引导射频消融治疗后血糖水平成功恢复正常。
核心结论
- 本病例强调新型诊断和治疗工具对优化胰岛素瘤患者管理的重要性。
研究设计与样本
- 病例报告:1例48岁女性高胰岛素性低血糖患者,常规形态学与功能学检查未发现肿瘤。
主要发现
- 68Ga-Exendin PET/CT检出2个亚厘米级胰腺胰岛素瘤。
- PET引导下双能光谱CT于术前确认病灶。
- 超声内镜引导射频消融治疗后血糖水平成功恢复正常。
临床怎么用
- 作者认为,本病例 underscores 新型诊断和治疗工具对优化胰岛素瘤患者管理的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report the case of a 48-year-old woman who presented with hyperinsulinemic hypoglycemia, suggestive of an underlying insulinoma. Conventional morphologic and functional work-ups failed to identify the tumor. A 68 Ga-Exendin PET/CT ultimately detected 2 subcentimetric pancreatic insulinomas. A conservative endoscopic ultrasound-guided radiofrequency ablation was performed. Before the procedure, a dual-energy spectral CT, guided by the PET findings, confirmed the lesions. This treatment successfully normalized blood glucose levels. This case underscores the importance of new diagnostic and therapeutic tools for the optimized management of patients with insulinomas.
引用
- Moreau A, Lhuillier R, Rivory J, et al. Bifocal Insulinoma Detected With 68 Ga-Exendin PET/CT and Treated With Endoscopic Ultrasound-guided Radiofrequency Ablation: Toward a Gold-Standard Management? Clin Nucl Med. 2025. PMID: 40474374. doi:10.1097/RLU.0000000000005774
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。